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Abstract
Colorectal cancer (CRC) is the third most common cancer 
and second leading cause of cancer-related death in the 
United States. Colonoscopy is widely preferred for CRC 
screening and is the most commonly used method in the 
United States. Adequate bowel preparation is essential 
for successful colonoscopy CRC screening. However, 
up to one-quarter of colonoscopies are associated with 
inadequate bowel preparation, which may result in re-
duced polyp and adenoma detection rates, unsuccessful 
screens, and an increased likelihood of repeat procedure. 
In addition, standardized criteria and assessment scales 
for bowel preparation quality are lacking. While several 
bowel preparation quality scales are referred to in the 
literature, these differ greatly in grading methodology and 
categorization criteria. Published reliability and validity 
data are available for five bowel preparation quality 
assessment scales, which vary in several key attributes. 
However, clinicians and researchers continue to use a 
variety of bowel preparation quality measures, including 
nonvalidated scales, leading to potential confusion and 
difficulty when comparing quality results among clinicians 
and across clinical trials. Optimal clinical criteria for bowel 
preparation quality remain controversial. The use of 
validated bowel preparation quality scales with stringent 
but simple scoring criteria would help clarify clinical trial 
data as well as the performance of colonoscopy in clinical 
practice related to quality measurements. 
Key words: Colonoscopy; Bowel preparation; Aronchick 
scale; Ottawa Bowel Preparation Scale; Boston Bowel 
Preparation Scale 
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Core tip: Adequate bowel preparation is essential for 
proper visualization of the colonic mucosa to optimize 
lesion detection for a successful colonoscopy. Clinicians 
and researchers continue to use a variety of bowel prep-
aration quality measures, including de novo, nonvalidated 
scales in clinical studies, leading to potential confusion, 
and creating difficulty when comparing bowel preparation 
quality results across clinical trials. Based on data eval-
uating different bowel preparation quality scales in the 
literature, and published criteria that define the most 
desirable measures to be used in such grading scales, the 
Boston Bowel Preparation Scale is currently recommended 
as standard. 
Kastenberg D, Bertiger G, Brogadir S. Bowel preparation 
quality scales for colonoscopy. World J Gastroenterol 2018; 
24(26): 2833-2843  Available from: URL: http://www.wjgnet.
com/1007-9327/full/v24/i26/2833.htm  DOI: http://dx.doi.
org/10.3748/wjg.v24.i26.2833
INTRODUCTION
Colorectal cancer (CRC) is the third most common 
cancer, with an estimated risk of occurring in 1 of 18 
persons during their lifetime, and is the second most 
common cause of cancer-related adult deaths in the 
United States[1,2]. Approximately 135000 new CRC cases 
and 50000 CRC deaths were projected to occur in 2017 
in the United States[1]. For average risk individuals, 
the United States Preventive Services Task Force and 
other public health and professional medical bodies 
recommend CRC screening using colonoscopy, com-
puterized tomography colonography, sigmoidoscopy, 
double-contrast barium enema, high-sensitivity guaiac or 
immunochemical fecal occult blood testing, or stool DNA 
testing (which is combined with immunochemical blood 
testing) beginning at the age of 50 years[2-4]. Colono-
scopy is a preferred and the most widely used method 
for CRC screening in the United States[4-6], based on data 
showing this procedure is correlated with decreased CRC 
incidence and deaths, most likely through the detection 
and removal of premalignant polyps[7-10]. 
Adequate bowel preparation is essential to ensure 
sufficient visualization of the colonic mucosa and to 
optimize lesion detection for successful colonoscopy 
utilized for CRC screening[4,11]. However, study data 
indicate that up to one-quarter of colonoscopies may 
be conducted with inadequate bowel preparation[12,13], 
which is correlated with lower detection of polyps and 
adenomas vs adequate preparation (typically good/
excellent quality)[12,14-16]. A meta-analysis of 27 studies 
found that inadequate bowel preparation for colonoscopy 
CRC screening reduced detection of small adenomas by 
47% (OR = 0.53, CI: 0.46-0.62; P < 0.001) vs adequate 
preparation (excellent/good/fair); this relationship was 
weaker but still significant for advanced adenomas 
(OR = 0.74, CI: 0.62-0.87; P < 0.001)[17]. Other 
studies have reported overall adenoma miss rates 
of 42%-48% for initial colonoscopies with inadequate 
or low-quality bowel preparation, based on findings at 
repeat colonoscopies[13,18]. Inadequate bowel preparation 
for colonoscopy may also result in prolonged procedures, 
more frequent repeat colonoscopies (at shorter 
than recommended intervals) and related increased 
costs, lower cecal intubation rates, and higher risk of 
electrocautery[6,11,19-21]. Studies in various international 
populations have found that inadequate cleansing is 
a factor in approximately 20%-70% of incomplete 
colonoscopies[22-25]. Professional gastroenterology 
societies recommend that clinical practices aim for mini-
mum adequate bowel preparation rates of 85%-90%, 
and that bowel preparation quality be documented at the 
time of the screening[6,26]. 
Currently, no standard criteria or definition exists 
for qualitative terms such as “adequate”, “inadequate”, 
“excellent”, “good”, “fair”, or “poor”; in some scales, 
adequate cleansing is defined as a composite of “good” 
and “excellent”[11,26]. Physician reporting on quality of 
bowel preparation, as well as overall colonoscopy quality, 
is highly inconsistent and often missing important ele-
ments, which may be attributable to lack of clear and 
consistent quality assessment standards[27]. Therefore, 
this review was conducted to summarize and discuss 
currently available bowel preparation quality scales and 
highlight the benefits of using a reliable and validated 
scale in both clinical practice and clinical trials of bowel 
preparation agents. 
COMPONENTS OF A BOWEL 
PREPARATION QUALITY SCALE
Essential attributes of a dependable bowel preparation 
quality scale include reliability and validity[11]. Scale 
reliability involves the degree to which an instrument 
yields reproducible, or consistent, results for the same 
investigator (intrarater reliability) or among different 
investigators (interrater reliability), upon repeated 
testing[11,28]. Validity indicates how well the scale mea-
sures what it is designed to assess, which can be 
determined via several methods[29]. Validity may be as-
sessed by comparison with results of other established 
and accepted scales used for the same purpose (i.e., 
bowel preparation quality) in the same test population, 
referred to as construct validity. Scale validity may also 
be assessed by correlation with other specific criteria 
measuring relevant clinical outcomes, in this case, overall 
colonoscopy quality; this is referred to as criterion-related 
validity or predictive validity[29,30]. 
A commonly used criterion for overall quality of CRC 
screening colonoscopy is the adenoma detection rate 
(ADR), defined as the proportion of all CRC screening 
colonoscopies performed by a physician that reveal 
2834 July 14, 2018|Volume 24|Issue 26|WJG|www.wjgnet.com
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at least one adenoma[6,31]. Studies have shown that 
colonoscopy ADR is strongly, inversely associated with 
reduced interval CRC rates (CRC diagnosed between 
the time of screening colonoscopy and the scheduled 
time of surveillance colonoscopy, which was up to 10 
years)[32,33], and that increasing ADRs are correlated 
with reduced CRC incidence and mortality[34]. Some 
data also indicate that the polyp detection rate (PDR), 
the number of patients with at least one polyp removed 
during screening CRC, may also be a useful parameter 
of colonoscopy quality, particularly since it appears to 
correlate well with ADR[6]. However, use of the PDR raises 
additional questions related to the precise definition of 
“polyp”. Other questions include whether the detection 
rates of sessile serrated polyps (SSPs), advanced 
adenomas, and multiple adenomas (as opposed to a “one 
and done” approach) should be used as key indicators 
of colonoscopy quality in addition to the ADR and PDR[6]. 
However, clinical data are insufficient for resolution 
of these issues, and no guidelines for correlation of 
bowel preparation quality with detection rates for SSPs, 
advanced adenomas, and multiple adenomas have yet 
been established[6]. Thus, ADR appears to be the best 
criterion currently available, as it is relatively easy to 
measure and has been shown to correlate with interval 
cancer rate.
The cecal intubation rate, an indicator of colonoscopy 
completion (reaching the cecum or anastomosis, if 
present), is another acknowledged quality measure[6,21,26]. 
Cecal intubation is essential for visualization of the proxi-
mal colon, including the caecum, where many colorectal 
neoplasms are located, in particular SSPs[6]. However, 
data on the independent association of cecal intubation 
rate with CRC risk have been mixed[32,35]. Longer with-
drawal time is associated with higher ADR and higher 
SSP detection and is also considered a key criterion of 
colonoscopy quality secondary to ADR[6,36-38]. 
Another recommended criterion of colonoscopy 
quality is the level of adherence to recommended post-
polypectomy and post-cancer surveillance intervals, which 
are based on study data[2,6,39,40]. The United States Multi-
Society Task Force on Colorectal Cancer (USMSTFCC) has 
recommended that this criterion may serve as the overall 
indication of clinical adequacy of a bowel preparation[11]. 
Intra-procedure flushing and suctioning to remove 
fluid and semisolid debris is often performed during 
colonoscopy[11]. Therefore, the USMSTFCC recommends 
that bowel preparation quality should be assessed on 
withdrawal after washing and suctioning[11]. This criterion 
relates primarily to clinical adequacy, where washing and 
suctioning is taken into account, and is less relevant for 
the comparison of different bowel preparation agents, 
where pre-wash grading of bowel cleanse quality may 
better reflect preparation agent efficacy.
VALIDATED BOWEL PREPARATION 
SCALES
The most well established and commonly used validated 
bowel preparation quality scales in clinical trials include 
the Aronchick Scale[41,42], the Boston Bowel Preparation 
Scale (BBPS)[43-49], and the Ottawa Bowel Preparation 
Scale (OBPS)[50] (Table 1). Other instruments that have 
been validated, but are less commonly used, include 
the Harefield Cleansing Scale (HCS)[51] and the Chicago 
Bowel Preparation Scale (CBPS)[52] (Table 1). A summary 
of validation studies is found in Table 2.
Aronchick scale 
The Aronchick Scale was the first bowel preparation 
quality scale to be evaluated for reliability[41,42]. This 
scale characterizes the percentage of the total colonic 
mucosal surface covered by fluid or stool, without scoring 
for separate colon segments, and is performed before 
washing or suctioning (Table 1). A validity study found 
that interobserver reliability kappa intraclass correlation 
coefficients (ICCs) were high for the cecum (0.76) and 
the total colon (0.77), but were reduced for the distal 
colon (0.31) and ascending colon segments[42]. The Aron-
chick Scale is one of the most commonly used validated 
bowel preparation quality scales in clinical trials and 
clinical practice. 
Ottawa Bowel Preparation Scale
The OBPS measures mucosal cleanliness by colon seg-
ment, including the right colon, mid-colon, and recto-
sigmoid colon, on a scale of 0 (excellent) to 4 (inadequate) 
for each (Table 1 and Figure 1), and is also scored 
before washing or suctioning[50]. However, in contrast to 
the Aronchick scale, the OBPS measures fluid quantity 
separately, with scores ranging from 0 (small volume) 
to 2 (large volume) for the total colon. Additionally, the 
OBPS does not tie scoring to subjective estimates of 
the percentage of the mucosa that is visible, which the 
investigators suggested might improve interobserver 
reliability (Table 1)[50]. In a study of reliability and 
validity compared with the Aronchick scale, the Pearson 
correlation coefficients for interobserver ratings were 
superior for the OBPS vs the Aronchick (0.89 vs 0.62, 
respectively; P < 0.001)[50]. Similarly, the kappa ICCs 
also significantly favored the OBPS vs the Aronchick scale 
[0.94 (95%CI: 0.91-0.96) vs 0.77 (95%CI: 0.65-0.84), 
respectively; P < 0.001]. Interrater consistency was 
found to be stronger with the OBPS vs the Aronchick 
scale, and reliability and agreement of the OBPS for the 
three different colon segments measured were very high, 
and not significantly different between segments (0.92 
kappa, right colon; 0.88 kappa, mid-colon; 0.89 kappa, 
rectosigmoid; 0.94 kappa, total colon). 
A prospective study of the OBPS aimed to identify an 
optimal cut-off score for bowel preparation adequacy/
inadequacy in 211 patients undergoing colonoscopy at 
a single center[53]. The receiver operating characteristic 
(ROC) analysis used in this study found that an OBPS 
score cutoff of ≥ 8 identified inadequate bowel prep-
aration with a sensitivity of 100% and a specificity 
of 91%. Another study in 150 consecutive patients 
undergoing colonoscopy reported strong concordance 
2835 July 14, 2018|Volume 24|Issue 26|WJG|www.wjgnet.com
Kastenberg D et al . Bowel preparation quality scales
2836 July 14, 2018|Volume 24|Issue 26|WJG|www.wjgnet.com
Scale name Score Rating/description Other scale properties/characteristics
Aronchick Scale 1 Excellent: Small volume of liquid; > 95% of mucosa 
seen
Total score range: Minimum 1 (excellent) to maximum 5 
(inadequate) 
Scoring performed before washing or suctioning
No separate ratings for segments; global colon rating only
No threshold for adequate/inadequate provided
2 Good: Clear liquid covering 5%-25% of mucosa, but 
> 90% of mucosa seen
3 Fair: Semisolid stool could not be suctioned or 
washed away, but > 90% of mucosa seen
4 Poor: Semisolid stool could not be suctioned or 
washed away and < 90% of mucosa seen
5 Inadequate: Repeat preparation/screening needed
Ottawa Bowel 
Preparation Scale 
(by colon segment)
0 Excellent: Mucosal detail clearly visible, almost no 
stool residue; if fluid present, it is clear, almost no 
stool residue
Total score (obtained by adding scores for each segment + total 
colon fluid score) range: Minimum 0 (excellent) to maximum 14 
(inadequate)
Scoring performed before washing or suctioning
Rates cleansing by colon segment: Right colon, mid-colon, and 
rectosigmoid colon (Figure 1)
No threshold for adequate/inadequate provided
1 Good: Some turbid fluid or stool residue, but 
mucosal detail still visible without need for 
washing/suctioning 
2 Fair: Some turbid fluid of stool residue obscuring 
mucosal detail; however, mucosal detail becomes 
visible with suctioning, washing not needed
3 Poor: Stool present obscuring mucosal detail 
and contour; a reasonable view is obtained with 
suctioning and washing
4 Inadequate: Solid stool obscuring mucosal detail 
and not cleared with washing and suctioning
Ottawa Bowel 
Preparation Scale 
(total colon fluid)
0 Small amount of fluid Total colon fluid score range: Minimum 0 (small amount of fluid) 
to maximum 2 (large amount of fluid)
Scoring performed before washing or suctioning
Single score for the total colon
No threshold for adequate/inadequate provided
1 Moderate amount of fluid
2 Large amount of fluid
Boston Bowel 
Preparation Scale 
(by colon segment)
0 Unprepared colon segment with mucosa not seen 
because of solid stool that cannot be cleared
Total score (obtained by adding scores for each segment) range: 
Minimum 0 (very poor) to maximum 9 (excellent)
Scoring performed after washing or suctioning
Segments separately rated: Right colon (including cecum and 
ascending colon); transverse (includes hepatic and splenic 
flexures); and left colon (descending and sigmoid colon, and 
rectum)
Threshold optimally is total score of ≥ 6 AND ≥ 2 per segment 
1 Portion of mucosa of the colon segment seen, but 
other areas of segment not well seen because of 
staining, residual stool, and/or opaque liquid
2 Minor amount of residual staining, small fragments 
of stool, and/or opaque liquid, but mucosa of colon 
segment is well seen
3 Entire mucosa of colon segment well seen, with 
no residual staining, small fragments of stool, or 
opaque liquid
Harefield Cleansing 
Scale (by colon 
segment)
0 Irremovable, heavy, hard stools Total score (obtained by adding scores for each segment) range: 
Minimum 0 (very bad) to maximum 20 (very good)
Scoring performed after washing or suctioning
Segments separately rated: Rectum, sigmoid, left, transverse, 
right colon
Threshold for successful cleansing = Grade A: no segment scored 
< 3 or 4, or Grade B: ≥ 1 segment scored 2 but no segment < 2; 
Unsuccessful cleansing = Grade C: ≥ 1 segment scored 1 but no 
segment < 1, or Grade D: ≥ 1 segment scored 0  
1 Semisolid, only partially removable stools
2 Brown liquid/fully removable semi-solid stools
3 Clear liquid 
4 Empty and clean
Chicago Bowel 
Preparation Scale
(by colon segment)
0 Unprepared colon segment with stool that cannot be 
cleared (> 15% of mucosa not seen)
Total score (obtained by adding scores for each segment) range: 
Minimum 0 (unprepared) to maximum 36 (excellent)
Scoring performed before (fluid) and after (mucosal cleaning) 
washing or suctioning
Segments separately rated: Right (cecum to mid-hepatic flexure), 
transverse (mid-hepatic flexure to mid-splenic flexure), and left 
colon (mid-splenic flexure to distal rectum)
No threshold for adequate/inadequate provided
5 Portion of mucosa in segment seen after cleaning, 
but up to 15% of the mucosa not seen because of 
retained material
10 Minor residual material after cleaning, but mucosa 
of segment generally well seen
11 Entire mucosa of segment well seen after washing
12 Entire mucosa of segment well seen before washing 
or suctioning
Chicago Bowel 
Preparation Scale 
(total colon) 
0 Little fluid (≤ 50 cc) Total score range: Minimum 0 (little fluid) to maximum 3 (large 
amount of fluid)
Scoring performed before washing or suctioning
No threshold for adequate/inadequate provided
Not incorporated into total score for segments
1 Minimal amount of fluid (51-150 cc)
2 Moderate amount of fluid (151-300 cc)
3 Large amount of fluid (> 300 cc)
Table 1  Validated bowel preparation scales
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Scale Study Colons 
(n )
Raters 
(n )
Reliability Validity
Aronchick Aronchick[41], 
2004 
80 5 ICC values for:
   Total colon: 0.77
   Cecum: 0.76
   Distal colon: 0.31 
NR
OBPS Rostom 
et al[50], 2004
97 2 ICC values for:
   Right colon: 0.92 
   Mid colon: 0.88
   Rectosigmoid colon: 0.89
Comparisons with Aronchick scale
   PCC: 0.89 OBPS vs 0.62 Aronchick 
   ICC: 0.94 OBPS vs 0.77 Aronchick
Chan 
et al[53], 2011
211 NR NR Cutoff scores for adequacy/inadequacy
   Optimal cutoff for inadequate ≥ 8: Sensitivity, 100%, specificity, 
91%
Martinato 
et al[54], 2013
150 NR Ratings of physicians vs nurses:
   PCC: r = 0.60
Correlations with VAS
   PCC (physicians vs nurses): r = 0.60
Lee 
et al[58], 2016
655 NA NR Comparison with BBPS for PDR and ADR
   PCC: r = -0.62 (P < 0.001); AUC of ROC analysis similar for PDR, 
ADR, right-sided adenomas, and SSAs 
BBPS Lai 
et al[47], 2009
633 22 ICC values:
   0.74/0.77 wtd κ
PDR by score
  40% for scores ≥ 5 vs 24% for scores < 5 (P < 0.02) 
Need for repeat CSP due to inadequate bowel prep
  2% for scores ≥ 5 vs 73% for scores < 5 (P < 0.001)
Correlation with colonoscope insertion time
   PCC:  r = -0.16 (P < 0.003)
Correlation with colonoscope withdrawal time
    PCC: r = -0.23 (P < 0.001)    
Calderwood 
et al[43], 2010 
119 12 ICC values for:
   Total colon: 0.91
   Right colon: 0.88
   Transverse colon: 0.83
   Left colon: 0.79
Correlations with ability to exclude polyps > 5 mm
   100%, 88%, 82%, 33%, and 0% of physicians deemed bowel 
preparation adequate to exclude polyps > 5 mm at scores of ≥ 8, 7, 6, 
5, and ≤ 4 respectively
Correlations with surveillance recommendations after normal CSP
   Score < 5: 100% recommended ≤ 1 yr
   Scores 5-6:  mean recommended interval 4.3 (± 3.9) yr
   Scores ≥ 7:  100% recommended 10 yr         
Calderwood 
et al[44], 2014
2516 74 NR Physician-recommended CSP interval after negative CSP
   Scores ≥ 6 (≥ 2 each segment): 90% recommended 10 yr 
   Scores 0-2: 96% recommended ≤ 1 yr 
Schindler 
et al[49], 2016
3 401 ICC values, all raters (all segment 
and total scores): 0.93
NR
Gao 
et al[45], 2013
1012 13 ICC values: 
   0.987/0.671 wtd κ
PDR
   Scores ≥ 5 superior vs < 5 (35% vs 18%; P < 0.05) 
Kim 
et al[46], 2014
482 6 ICC values: 
   Total colon: 0.90/0.63 wtd κ
   Right colon: 0.93/0.91 wtd κ
   Transverse colon: 0.88/0.86 wtd κ
   Left colon: 0.50/0.38 wtd κ  
PDR
  Scores ≥ 8 superior vs scores < 8 (44.9% vs 33.0%; P = 0.04)
Colonoscope withdrawal time
   PCC: r = -0.167 (P < 0.001)
Colonoscope insertion time
   PCC: r = 0.018 (P = 0.695)
Clark 
et al[57], 2016
438 4 ICC values by BBPS scores:
  0 and 3: 1.0
  2: 0.81
  1: 0.80   
ADR (> 5 mm) miss rates by BBPS score:
   3: 5.6%
   2: 5.2%
   1: 15.9%
   Score of 2 noninferior to 3 for missed adenoma > 5 mm
HCS Halphen 
et al[51], 2013
337 4 ICC value: 
0.457
Test-retest κ values:
   Range, 0.33 to 0.85
Intrarater2: 
   0.28 to 0.64
Internal consistency3: 
   0.81, 0.86
Best score cutoff for satisfactory bowel preparation 
   ≥ 2 for each segment: Sensitivity, 99% and specificity, 83%
Correlation with Aronchick scale 
   PCC: r = 0.833
AUC of ROC analysis (vs Aronchick scale scores) 
   0.945 for total colon
CBPS Gerard 
et al[52], 2013
150 44 ICC values for: 
   Range, 0.624 to 0.702 for all 
segments 
Correlations of scores with adequate cleansing 
   Adequate: Scores of 25-36 (≥ 95% of mucosa visualized) 
   Inadequate: Scores of 0-24 (< 95% of mucosa visualized) 
Table 2  Reliability and validation data for bowel preparation scales
1Raters included endoscopy nurses (n = 17), gastroenterology faculty (n = 14), and gastroenterology fellows (n = 9); 2Generalized κ for global agreement; 
3Cronbach’s alpha; 4Raters included three gastroenterologists and one physician’s assistant. ADR: Adenoma detection rate; AUC: Area under the curve; 
BBPS: Boston Bowel Preparation Scale; CBPS: Chicago Bowel Preparation Scale; CSP: Colonoscopy; HCS: Harefield Cleansing Scale; ICC: Interobserver 
reliability kappa intraclass correlation coefficient; NA: Not applicable; NR: Not reported; OBPS: Ottawa Bowel Preparation Scale; PCC: Pearson correlation 
coefficient; PDR: Polyp detection rate; ROC: Receiver operating characteristic; SSA: Sessile serrated adenoma; VAS: Visual analogue scale; wtd: Weighted. 
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between the OBPS and a visual analogue scale mea-
suring bowel cleansing among both nurses (r = 0.8268) 
and physicians (r = 0.8095), P < 0.0001 for both[54]. The 
concordance in scoring between nurses and physicians 
was r = 0.6010; P < 0.0001.
Boston Bowel Preparation Scale
The BBPS has been validated in multiple clinical stud-
ies[11,47,55]. Developed in 2009, this scale was designed 
to address specific issues affecting bowel preparation 
quality and scoring: (1) The scale stipulates that scoring 
is to be conducted upon withdrawal and after all flushing 
and suctioning of fluid have been completed; (2) scoring 
is applied by colon segments, as in the OBPS, based 
on potential for variance in bowel preparation between 
segments; and (3) subjective, qualitative terms, such as 
excellent, good, fair, or poor, are replaced by numbered 
scores that are correlated to more clearly described colo-
nic conditions, including features such as staining, liquid, 
and stool fragments (Table 1)[47]. Each segment of the 
colon is scored from 0 to 3, with higher scores indicating 
superior cleansing, and summed for a total score that 
can range from 0 to 9 (Table 1). 
The initial validation study for the BBPS involved 
633 CRC screening colonoscopies in a single center, 
and was applied by endoscopists who had undergone 
training on how to use the scale before participating in 
the study[47]. The median BBPS total score was 6. The 
ICC for interobserver agreement of total BBPS scores 
was 0.74 (95% predictive interval: 0.67-0.80), and 
the weighted kappa value for intraobserver agreement 
was 0.77 (95%CI: 0.66-0.87)[47]. Validity assessment 
was based on the correlations of BBPS scores with 
relevant clinical outcomes and more traditional scale 
categories, including “excellent”, “good”, “fair”, “poor”, 
or “unsatisfactory”. Of the 633 patients who received a 
CRC screening colonoscopy, 243 (38%) had at least one 
polyp detected, and the PDR was significantly higher 
for patients with BBPS scores ≥ 5 vs those for patients 
with BBPS score < 5 (40% vs 24%, respectively; P < 
0.02). The frequency of repeat colonoscopy attributable 
to inadequate bowel preparation was significantly higher 
in patients with scores < 5 vs those with scores ≥ 5 
(73% vs 2% of cases, respectively; P < 0.001). Total 
BBPS scores were inversely associated with colonoscopic 
insertion (r = -0.16; P < 0.003) and withdrawal times 
(r = -0.23; P < 0.001). In addition, a significant trend 
in mean BBPS score correlating with excellent, good, 
fair, poor, or unsatisfactory, as separately scored by the 
raters, was observed (P < 0.001 for trend). 
A follow-up study investigated interobserver reliability 
and clinical outcome correlations of BBPS scores for 
individual segments, and relationship of scores to polyp 
detection in 119 screening colonoscopies rated by nine 
full-time faculty and three fellows at a single center[43]. All 
(100%) raters judged the bowel preparation adequate to 
exclude polyps > 5 mm with a ≥ 8 BBPS score, vs 88% 
of physicians when the score was 7, 82% when the score 
was 6, 33% when the score was 5, and 0% with a score 
of ≤ 4. Thus, a score of ≥ 6 was a particularly important 
threshold, since approximately 80% of physicians found 
the bowel preparation adequate at that score vs only 
one-third or less at BBPS scores of ≤ 5. In patients who 
had undergone a normal screening colonoscopy, a score 
of < 5 prompted all physicians to recommend repeat 
colonoscopy within one year, while a score of ≥ 7 was 
correlated with a recommendation for the next colonoscopy 
to occur in 10 years (among all physicians). BBPS segment 
scores were positively correlated with improved PDRs for 
the left and right colon, but no association was found for the 
transverse colon.
A further validation study was aimed at identifying 
a cut-off score for adequacy/inadequacy of bowel prep-
aration[44]. This retrospective study of 2516 normal CRC 
screening colonoscopies performed by 74 endoscopists 
found that follow-up was recommended in 10 years 
for 90% of cases with a total BBPS score ≥ 6 in which 
all three segments had scores ≥ 2 (n = 2295), while 
96% of examinations with total BBPS scores of 0-2 (n 
= 26) recommended follow-up within one year (Figure 
2). Screenings with total scores of 3-5 (n = 167) had 
variable recommendations. Based on these findings, 
the investigators suggested that a total BBPS score 
of ≥ 6 and/or all segment scores ≥ 2 may serve as a 
standard definition of “adequate for 10-year follow-up”[44]. 
However, a prospective, observational study in a large, 
national endoscopic consortium found that inadequate 
single BBPS segment scores at the initial, average-risk 
screening colonoscopy were correlated with significantly 
greater risk of polyps at a second colonoscopy, sug-
gesting that both a total score of ≥ 6 and all segment 
scores ≥ 2 should be required as an adequacy standard 
for 10-year follow-up[56]. This assessment was affirmed 
by a study in 438 colonoscopies in men, which found that 
BBPS segment scores of 2 or 3 (with 2 being noninferior 
to 3) was indicative of adequate bowel preparation for 
detection of adenomas > 5 mm, and for repeat colo-
noscopy at standard, guideline-recommended intervals 
(both parameters are USMSTFCC-recommended criteria 
for bowel preparation adequacy)[11,57].
Right Rectosigmoid
Mid
Figure 1  Bowel preparation quality scale segments. Depiction of bowel 
segments from validation study of Ottawa Bowel Preparation Scale[50]. Before 
washing or suctioning, each segment is scored on a scale of 0-4 for cleansing, 
and the total colon is scored for fluid quantity on a scale of 0-2. The total score 
ranges from 0 (excellent) to 14 (inadequate).
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Harefield Cleansing Scale 
The HCS, developed in the 1990s, is scored by colon 
segment, as are the OBPS and BBPS[51]. Like the BBPS, 
the HCS is also scored after washing and suctioning 
are completed, and replaces qualitative terms (e.g., 
“excellent” or “good”) with direct descriptions of clean-
sing quality correlated with score numbers (Table 1)[51]. 
Grading is performed in five colon segments and ranges 
from 0-4 (higher numbers indicating better quality of 
cleanse) for each. Although total scores are derived by 
adding the separate segment scores, an “acceptable” 
score is possible only when the mucosa is 100% visible 
in all five colon segments. A validation study of the HCS 
compared with the Aronchick scale in 337 colonoscopies 
reviewed by four gastroenterologists found that there 
was a high degree of Pearson correlation between the 
two scales (r = 0.833), and the Spearman correlation 
coefficient was -0.778 (correlation is negative because 
improved cleanse quality is represented by different 
directions in the HCS and Aronchick scale)[51]. The ROC 
curve analysis vs the Aronchick scale showed an area 
under the curve of 0.945, and a sensitivity of 99% and 
specificity of 83% at the optimum score cut-off point. 
Interrater reliability analysis yielded an ICC of 0.457 
(95%CI: 0.366-0.539). Cohen kappa scores for individual 
segments between investigators showed slight-to-fair 
agreement ranging from 0.15-0.27. Internal consistency 
was acceptable, based on a Cronbach alpha coefficient of 
0.81, and the test-retest reliability assessment showed 
an overall kappa of 0.639. No analyses of correlations 
with relevant clinical outcomes such as the ADR or 
adherence to recall guidelines were performed, due to 
insufficient patient population. 
Chicago Bowel Preparation Scale
Like the HCS, the CBPS was developed to address 
perceived limitations in other commonly used bowel 
preparation scales[52]. The main features of the scale are 
shown in Table 1. Scoring is performed both before and 
after washing or suctioning, and a separate fluid score 
is included as a secondary measure (not incorporated 
into the total score as in the OBPS). The total and fluid 
scoring categories were designed to measure both 
the quality of visualization and the intraprocedural ef-
fort required to clean the mucosa to attain adequate 
visualization. These parameters were intended to help 
clinicians assess the cleansing efficacy of different bowel 
preparations[52]. A CBPS validation study prospectively 
compared the results of the CBPS with the OBPS, 
the BBPS, and a theoretical, dichotomous scale that 
simply defined “adequate cleansing” as ability to see 
≥ 95% of the mucosa (after it was cleansed), with 
“inadequacy” being defined as visibility in < 95% in 150 
colonoscopies at a single center[52]. In this study, kappa 
coefficients for interrater agreement were higher for 
the CBPS (0.624-0.702) than the OBPS (0.493-0.655) 
and the BBPS (0.545-0.661), but these differences 
were not significant. Kappa coefficients for the total 
colon fluid scores for the CBPS and OBPS, and Pearson 
correlations coefficients for interrater agreement, were 
also similar. For the OBPS, scores from 8-10 were graded 
inadequate; for the BBPS, a score of ≤ 4 was graded 
inadequate; and for the CBPS, total scores ≤ 24 were 
graded inadequate. No clinically relevant parameters 
were assessed for validation in this study. 
ADDITIONAL VALIDATED SCALE 
COMPARISON DATA
The OBPS and the BBPS were compared in a study that 
reviewed prospectively collected data from patients who 
underwent CRC screening or surveillance colonoscopies 
over a two-year period between August 2013 and July 
2015[58]. Of the 655 colonoscopies, overall detection rates 
for polyp, adenoma, right-side adenoma, and sessile 
serrated adenoma (SSA) were 42.8%, 32.8%, 20.8%, 
and 1.2%, respectively. A significant Pearson correlation 
was observed between the two scales (P < 0.001). 
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Figure 2  Percentage of screening colonoscopy examinations in which 10-year follow-up was recommended after a negative colonoscopy, stratified by 
total Boston Bowel Preparation Scale Score[44].
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However, the ROC curves for the OBPS vs the BBPS 
were not significantly different for the detection rates, 
respectively, for polyps (0.550 vs 0.513), adenoma (0.544 
vs 0.519), right-side adenoma (0.469 vs 0.516), and SSA 
(0.712 vs 0.790). The investigators concluded that the 
choice of either the OBPS or the BBPS may not strongly 
affect the measurement of bowel preparation quality.
DISCUSSION
Quality scales
All currently available bowel preparation quality scales 
are imperfect, have limitations, and are dependent upon 
subjective descriptions of luminal contents expressed 
as categories (“excellent”, “good”, etc.) or numbers, 
depending on the scale utilized. A standard, fully vali-
dated, and universally accepted scale for use in clinical 
practice and trials has not yet been established. Among 
the scales, the Aronchick scale is the most well-known 
and widely used clinically and in clinical trials to date; 
however, this scale rates cleanse quality of the colon as 
a whole and provides no details regarding differences 
between individual segments.
Colon segments cleansing
Guidance is somewhat vague for clinicians regarding 
grading of the entire colon when individual segments 
are suboptimally cleansed. This issue may arise more 
often in the proximal colon, which is harder to clean 
than other segments and more likely to contain flat 
lesions such as sessile serrated polyps/adenomas[50,51]. 
Segment-specific bowel preparation quality scales, such 
as the OBPS or BBPS, may provide a clearer distinction 
between cleanse quality of the proximal colon compared 
with other segments. Furthermore, establishing a mini-
mum acceptable score for adequacy within each colon 
segment, as has been done for the BBPS, is helpful in 
determining overall colon cleansing adequacy. A BBPS 
validation study provided information used to create an 
“adequate cleansing” threshold score of at least 2 in each 
of three colon segments.
Need for washing and suctioning
Grading before or after washing and suctioning is another 
important factor which differs between scales. Many 
clinicians are using the Aronchick scale incorrectly, as 
they grade the bowel preparation as good or fair after 
washing and suctioning. While scales that grade cleanse 
quality after washing may correlate better with quality 
measures such as ADR, or the likelihood of an alteration 
in CRC screening follow-up recommendations, scales 
that grade before washing can provide a better reflection 
of a bowel preparation product’s efficacy independent of 
the endoscopist. Similarly, the OBPS gives points based 
on the total fluid in the colon, which leads to inaccurate 
grading if using water immersion/exchange.
The OBPS entails scoring by colon segments, thus 
accounting for variation by segment in bowel prep-
aration quality/visibility; however, it also incorporates the 
presence of luminal fluid before suctioning[11,50]. The OBPS 
validation data are largely dependent on correlations with 
the Aronchick scale, which itself has limited validation 
and may not correlate with ADR[50]. The BBPS differs 
in several key aspects from the Aronchick and OBPS 
scales[47]. To begin, it requires washing and suctioning to 
be completed before the bowel preparation is graded[47]. 
The HCS requires rating only after completion of flushing 
and suctioning, providing a score for the entire colon as 
well as for individual segments[51,52]. 
Grading scales validity and reliability
The reliability and validation data for BBPS is more ex-
tensive compared with the Aronchick and OBPS scales 
and include good supporting data correlating scores 
with key clinical outcomes. These validation studies 
have provided information to create a threshold for 
adequate cleansing of a score of at least 2 in each of 
three colon segments[44,57]. It should also be noted, 
however, that one study found no significant difference 
between the BBPS and OBPS regarding key indicators 
of colonoscopy quality, such as the PDR and ADR, in 
screening or surveillance colonoscopy[58]. Concerning the 
HCS and CBPS, each has reported acceptable reliability 
data, although the CBPS validation study was based 
on findings from only two raters[51,52]. While the HCS 
validation assessment was the only one to provide test-
retest and internal consistency data for reliability, its 
validity evaluation was based only on correlations with 
the Aronchick scale[51]. Although the CBPS was compared 
with the OBPS and BBPS, no correlations of this scale 
with key clinical outcomes, such as ADR and adherence 
to screening and surveillance colonoscopy intervals, have 
been reported[52]. The CBPS has more specific definitions 
and requires measurement of fluid suctioned (Table 1), 
but the complexity may be challenging for the clinician 
to assess correctly; thus, it may not easily translate to 
clinical practice. Hence, the usefulness of these scales for 
clinical practice or trials remains unclear. 
Several unique, nonvalidated bowel preparation 
scales have been developed for use in trials of agents 
including oral sulfate solution (OSS) (Suprep®, Braintree 
Laboratories, Braintree, MA, United States)[59], OSS 
plus sulfate-free electrolyte lavage solution (Suclear®, 
Braintree Laboratories, Braintree, MA, United States)[60], 
and polyethylene glycol electrolyte solution plus ascorbic 
acid (MoviPrep®, Salix Pharmaceuticals, Bridgewater, NJ, 
United States)[59,61,62]. The grading criteria used in these 
study- and product-specific scales often differ greatly 
from validated scales. 
The substantial ramification of using nonvalidated 
scales is illustrated by a post hoc analysis of data from 
two sodium picosulfate and magnesium citrate (P/MC) 
clinical trials. Investigators analyzed the data from the 
studies after altering the definition of “adequate” in the 
Aronchick scale, which had been used in the original 
trials, to more closely resemble what has been used 
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in some studies utilizing nonvalidated scales[55]. With 
this revised definition, > 98% of all P/MC patients were 
considered responders, compared with 79%-87% using 
the original OBPS and Aronchick scale categorization cri-
teria. Multiple studies have used more than one validated 
scale from among the Aronchick, OBPS, and BBPS scales 
for assessment of bowel preparation quality, providing 
additional comparative data[63-70]. Generally, the results 
of these trials have been concordant in assessment of 
bowel preparation quality, with similar mean total scores 
being reported for overall quality, and similar comparative 
assessments of different bowel preparations.
While scales for assessment of bowel preparation 
quality for CRC screening colonoscopy have improved, 
establishing a standard, validated scale is essential to 
optimize CRC colonoscopy screening. The Boston bowel 
preparation scale has several limitations, but appears 
nonetheless to be the best available option, and is there-
fore recommended as the current standard for use in 
clinical practice. Given the importance preparation plays 
in multiple colonoscopy quality measures, including 
the need to repeat the procedure when cleansing is 
inadequate, it may be advantageous for clinicians to 
adopt one language to describe cleansing quality. The 
continued use of multiple scales with varying criteria may 
undermine the validity of study findings and the accuracy 
of colonoscopy for CRC screening and surveillance.
For colonoscopy clinical trials, the use of different, 
and sometimes nonvalidated, scales across studies is 
one of many reasons comparisons between studies is 
fraught with difficulties. By incorporating a standard, 
validated grading scale, we may ensure that the findings 
are generalizable and comparable with other studies and 
facilitate progress in the development of future bowel 
preparations. Future developments in bowel preparation 
quality assessment are likely to involve establishment 
of an improved “gold standard” and further refinement 
of the accuracy of quality assessment. Continued im-
provement of quality standards for CRC prevention, 
further studies of ADR and withdrawal time, and recom-
mended years of follow-up are also warranted.
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